Evan Feinberg is the founder of Genesis Therapeutics. Genesis Therapeutics has raised $300M in total funding. Latest round: Series B.
Evan Feinberg is the Co-founder and CEO of Genesis Therapeutics, an AI-driven drug discovery company focused on small-molecule design. He has scaled Genesis to over 100 employees and secured more than $300 million in funding from investors like Andreessen Horowitz and NVIDIA's venture arm.
Full founder directory · Investor directory · Company funding database · Fundraising library